P2X4 Inhibitor Solid Dispersion for Solubility and Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing P2X4 inhibitor compounds suffer from poor dissolution effects, necessitating the development of formulations that enhance their solubility and stability.
Innovation Solution
A solid dispersion of P2X4 inhibitors is formulated using active ingredients like compounds 1 to 48 combined with carriers such as copovidone, povidone, and surfactants like sodium lauryl sulfate, prepared via spray drying, solvent evaporation, or hot-melt extrusion methods, to improve solubility and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If P2X4 inhibitor compounds are used as pure substances, then their pharmacological activity is maintained, but their dissolution effect is poor
Solution Approach 1:
The patent applies composite materials by formulating P2X4 inhibitor compounds with solubility-enhancing excipients such as surfactants (e.g., polysorbate 80, polyoxyl 40 hydrogenated castor oil), co-solvents (e.g., ethanol, propylene glycol), and pH-adjusting agents. This composite formulation improves dissolution without compromising pharmacological activity, as the excipients are selected to be pharmaceutically compatible and non-interfering with the drug's mechanism of action.
Solution Approach 2:
The patent employs parameter changes by adjusting the pH of the formulation to optimize solubility of the P2X4 inhibitor compounds. By controlling pH within specific ranges using buffers or pH-adjusting excipients, the dissolution rate and extent are enhanced while maintaining the compound's stability and biological activity. This parameter optimization resolves the contradiction between poor dissolution and maintained efficacy.
2Ease of manufacture
If solubility-enhancing excipients are added to improve dissolution, then dissolution effect is improved, but formulation complexity increases
Solution Approach 1:
The patent applies universality by selecting excipients that perform multiple functions simultaneously. For example, polysorbate 80 serves both as a surfactant to enhance wetting and dissolution, and as a stabilizer to prevent degradation of the P2X4 inhibitor compounds. Similarly, polyoxyl 40 hydrogenated castor oil provides both solubility enhancement and preservative effects. This multi-functionality reduces the total number of excipients needed, thereby limiting formulation complexity while achieving improved dissolution.
Solution Approach 2:
The patent employs commonly available, inexpensive excipients with well-established safety profiles and regulatory acceptance. These excipients are readily obtainable and require minimal special handling or processing, simplifying manufacturing operations. By choosing widely used materials over novel or specialized excipients, the formulation achieves enhanced dissolution without proportionally increasing complexity or cost.
3Ease of manufacture
If multiple preparation methods are developed to enhance solubility, then dissolution effect is improved, but manufacturing process complexity increases
Solution Approach 1:
The patent replaces complex mechanical processing methods with simpler solution-based approaches. Instead of requiring advanced solid-state processing techniques or specialized equipment for particle engineering, the invention achieves enhanced dissolution through solution formulation methods using solubility-enhancing excipients. This substitution of approach reduces manufacturing process complexity while maintaining or improving dissolution performance.
Solution Approach 2:
The patent utilizes parameter changes in the formulation composition to achieve improved dissolution without altering the fundamental manufacturing process. By optimizing the types and amounts of excipients (surfactants, co-solvents, pH adjusters), the formulation achieves enhanced solubility using conventional mixing and processing techniques, thereby avoiding the need for complex multi-step manufacturing procedures or specialized equipment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solid dispersion significantly enhances the solubility and stability of P2X4 inhibitors, maintaining low impurity levels and facilitating effective pharmacokinetic profiles, while allowing for simple and solvent-compliant preparation methods.
Implementation Method 1
A solid dispersion of P2X4 inhibitors is formulated using active ingredients like compounds 1 to 48 combined with carriers such as copovidone, povidone, and surfactants like sodium lauryl sulfate
Implementation Method 2
The solid dispersion significantly enhances the solubility and stability of P2X4 inhibitors
Implementation Method 3
prepared via spray drying, solvent evaporation, or hot-melt extrusion methods
Implementation Method 4
prepared via spray drying, solvent evaporation, or hot-melt extrusion methods
Data Source
AI summary
A solid dispersion of a P2X4 inhibitor, comprising an active ingredient and a carrier. The obtained solid dispersion can improve the solubility and dissolution effect of the active ingredient, has a good stability, and has no obvious increase in impurities under 25°C/60% RH (open) and 40°C/75% RH (open) conditions. The method for preparing the solid dispersion is simple. The solid dispersion can be prepared using a spray drying method, a solvent method, or a hot-melt extrusion method, and the solvent residue content in the obtained product is qualified. Furthermore, the obtained solid dispersion effectively improves the pharmacokinetic effect of the active ingredient. A pharmaceutical composition containing the solid dispersion. The pharmaceutical composition has a good disintegration effect, and the disintegration time is within pharmacopoeial limits. Therefore, the pharmaceutical composition provides convenience for the development of subsequent dosage forms of the active ingredient.